Cargando…

Identifying treatment response to antihypertensives in patients with obesity-related hypertension

BACKGROUND: In patients with obesity-related hypertension (ORH), reaction to antihypertensive medication is likely influenced by patientcharacteristics. METHODS: Effects of aliskiren, moxonidine and hydrochlorothiazide on 24-h blood pressure (BP) were compared to placebo. Linear mixed effect models...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schrover, Ilse M., Dorresteijn, Jannick A. N., Smits, Jodine E., Danser, A. H. Jan, Visseren, Frank L. J., Spiering, Wilko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654008/ https://www.ncbi.nlm.nih.gov/pubmed/29085669 http://dx.doi.org/10.1186/s40885-017-0077-x

Ejemplares similares

The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease
por: Schrover, Ilse M, et al.
Publicado: (2018)

Drug Mechanisms to Help in Managing Resistant Hypertension in Obesity
por: Jansen, Pieter M., et al.
Publicado: (2010)

The daily 10 kcal expenditure deficit: a before-and-after study on low-cost interventions in the work environment
por: Dorresteijn, Johannes A N, et al.
Publicado: (2013)

Plasma Trough Concentrations of Antihypertensive Drugs for the Assessment of Treatment Adherence: A Meta-Analysis
por: Groenland, Eline H., et al.
Publicado: (2020)

Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives
por: Jaspers, Nicole E M, et al.
Publicado: (2018)

Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2020)

Smartphone Application-Assisted Home Blood Pressure Monitoring Compared With Office and Ambulatory Blood Pressure Monitoring in Patients With Hypertension: the AMUSE-BP Study
por: Groenland, Eline H., et al.
Publicado: (2022)

Baroreflex Amplification and Carotid Body Modulation for the Treatment of Resistant Hypertension
por: Groenland, Eline H., et al.
Publicado: (2020)

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
por: Stam‐Slob, Manon C., et al.
Publicado: (2017)

Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?
por: Berkelmans, Gijs F. N., et al.
Publicado: (2020)

Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care
por: de Beus, Esther, et al.
Publicado: (2017)

Use of Antihypertensive Drugs and Ischemic Stroke Severity – Is There a Role for Angiotensin-II?
por: Hwong, Wen Yea, et al.
Publicado: (2016)

Endovascular Baroreflex Amplification for Resistant Hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2018)

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016)

Identifying poor adherence to antihypertensive medications in patients with resistant hypertension
por: Mackenzie, Isla S., et al.
Publicado: (2018)

Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
por: Gynnild, Mari Nordbø, et al.
Publicado: (2022)

Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease
por: van de Woestijne, Anton P., et al.
Publicado: (2014)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease
por: Groenland, Eline H., et al.
Publicado: (2022)

Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention
por: Gynnild, Mari Nordbø, et al.
Publicado: (2021)

The relationship between walking speed and changes in cardiovascular risk factors during a 12-day walking tour to Santiago de Compostela: a cohort study
por: Bemelmans, Remy H H, et al.
Publicado: (2012)

Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial
por: Jaspers, Nicole E M, et al.
Publicado: (2021)

Blood pressure response to commonly administered antihypertensives for severe inpatient hypertension
por: Ghazi, Lama, et al.
Publicado: (2022)

Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment
por: Ghazi, Lama, et al.
Publicado: (2022)

Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction
por: van Kruijsdijk, Rob C M, et al.
Publicado: (2022)

Predictors of uncontrolled hypertension and antihypertensive medication nonadherence
por: Morgado, Manuel, et al.
Publicado: (2010)

Preventing the Progression of Prehypertension to Hypertension: Role of Antihypertensives
por: Fuchs, Flávio Danni, et al.
Publicado: (2014)

Adherence to Antihypertensive Medication in Older Adults With Hypertension
por: Lo, Suzanne H. S., et al.
Publicado: (2016)

Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy
por: Cataldi, Mauro, et al.
Publicado: (2016)

Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings
por: Quinn, Amity E., et al.
Publicado: (2021)

Effect of antihypertensive therapy on cognitive functions of patients with hypertension
por: Jaiswal, Ashok, et al.
Publicado: (2010)

Antihypertensive Effect of Syzygium cumini in Spontaneously Hypertensive Rats
por: Ribeiro, Rachel Melo, et al.
Publicado: (2014)

Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats
por: Dubey, Harikesh, et al.
Publicado: (2017)

Hypertension, Antihypertensive Use and the Delayed‐Onset of Huntington's Disease
por: Steventon, Jessica J., et al.
Publicado: (2020)

Factors affecting the changes in antihypertensive medications in patients with hypertension
por: Chung, Tae Kyu, et al.
Publicado: (2022)

Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
por: Zhu, Yahui, et al.
Publicado: (2023)

Physical exercise volume, type, and intensity and risk of all-cause mortality and cardiovascular events in patients with cardiovascular disease: a mediation analysis
por: Bonekamp, Nadia E, et al.
Publicado: (2023)

Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension
por: Lubas, Arkadiusz, et al.
Publicado: (2010)

Human essential hypertension: no significant association of polygenic risk scores with antihypertensive drug responses
por: Sánez Tähtisalo, Heini, et al.
Publicado: (2020)

The effect of endovascular baroreflex amplification on central sympathetic nerve circuits and cerebral blood flow in patients with resistant hypertension: A functional MRI study
por: Groenland, Eline H., et al.
Publicado: (2022)

Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment Resistance
por: Calhoun, David A.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gqgf5678g715hi74ke1q89hm23